Updated analysis: Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802)—Sub-group analysis by KRAS Exon2 status.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michio Nakamura, Satoshi Yuki, Kentaro Sawada, Ayane Oba, Atsushi Sato, Takashi Kato, Takashi Meguro, Nobuyuki Ehira, Miki Tateyama, Kazuteru Hatanaka, Kazunori Eto, Hiroyuki Okuda, Yoshimitsu Kobayashi, Osamu Muto, Masakazu Abe, Kanji Kato, Mineo Kudo, Kencho Miyashita, Yuh Sakata, Yoshito Komatsu
Institutions: Sapporo City General Hospital, Hokkaido University Hospital, Hirosaki University, Hokkaido Gastroenterology Hospital, Japanese Red Cross Kitami Hospital, Hakodate Municipal Hospital, Tomakomai City Hospital, Keiyukai Sapporo Hospital, Akita Red Cross Hospital, Sapporo Kosei General Hospital, Sapporo Hokuyu Hospital, Misawa City Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589533643